Author

Jared K. Slone

Rice UniversityORCID 0000-0002-6629-4166Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:imaging· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Alexandre ReubeniD· 2 shared Amanda MontoyaiD· 2 shared Anika PateliD· 2 shared Emily BontekoeiD· 2 shared Isabella PoliciD· 2 shared Jianjun ZhangiD· 2 shared John Victor HeymachiD· 2 shared Lydia E. KavrakiiD· 2 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Alexandre ReubenORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Distinct Spatial Immune Architectures in Tumor and Tumor-Adjacent Tissues of Early-Stage Non-Small Cell Lung Cancer

Isabella Polic, Claudio A. Arrechedera, Jared K. Slone, Amanda Montoya, Emily Bontekoe, Peixin Jiang, Anika Patel, Tatiana V. Karpinets, Xiaogang Wu, Xingzhi Song, Qianyun Luo, Heladio P. Ibarguen, Auriole Tamegnon, Mei Jiang, Cara Haymaker, , Alexandre Reuben

This study compares spatial immune architectures in tumor and tumor-adjacent tissues of early-stage NSCLC, finding distinct immune cell densities, spatial patterns, and associations with genomic features and patient outcomes.

bioRxiv · Sep 14, 2026 · PreprintImmunology

HER2 mutation-derived neoantigens in NSCLC as actionable targets for TCR therapy

Amanda Montoya, Hui Nie, Peixin Jiang, Jared K. Slone, Yulia V. Shulga, Anika Patel, Prashant S. Menon, Isabella Polic, Emily Bontekoe, Lingzhi Hong, Minying Zhang, Emane Rose Assita, Sarah Forward, Changsheng Xing, Bo Jiang, , Alexandre Reuben

The paper identifies TCRs targeting HER2 mutations in NSCLC, showing they recognize mutant epitopes and maintain cytotoxic activity, offering a potential immunotherapy strategy.

bioRxiv · Aug 4, 2026 · PreprintImmunology